Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Type of study
Publication year range
1.
Gan To Kagaku Ryoho ; 46(2): 294-296, 2019 Feb.
Article in Japanese | MEDLINE | ID: mdl-30914538

ABSTRACT

This case involved a 28-year-old female with rectal cancer in the inner pelvis. Two courses of SOX plus Cmab therapy, and 4 courses of FOLFOX-Cmab therapy were administered as preoperative chemotherapies, which resulted in a reduction in the major lesion. Subsequently, laparoscopic low anterior resection and dissection of the bilateral lymph nodes were performed. After the surgery, adjuvant chemotherapy with FOLFOX was administered. Afterwards, the patient developed severe anal pain and visited us for treatment. The severe anal pain continued even after FOLFOX treatment and increased with defecation. A side effect of oxaliplatin was suspected, and sLV5FU chemotherapy was administered. As a result, the anal pain disappeared. Thus, the pain was considered to be induced by oxaliplatin. While peripheral neuropathy is a widely known side effect of oxaliplatin, this case was considered to be unique because anal pain occurs very rarely with oxaliplatin treatment.


Subject(s)
Antineoplastic Agents , Oxaliplatin , Pain , Rectal Neoplasms , Adult , Antineoplastic Agents/adverse effects , Antineoplastic Agents/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Female , Humans , Organoplatinum Compounds , Oxaliplatin/adverse effects , Oxaliplatin/therapeutic use , Pain/chemically induced , Pain/etiology , Rectal Neoplasms/complications , Rectal Neoplasms/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...